Home About us Contact
|
Home About us Contact | ||
|
|
||
Fermentation Technology (fermentation + technology)
Selected AbstractsAlternative technologies for biotechnological fuel ethanol manufacturingJOURNAL OF CHEMICAL TECHNOLOGY & BIOTECHNOLOGY, Issue 8 2007Alain A Vertès Abstract The challenges of implementing biorefineries on a global scale include socioeconomic, financial, and technological constraints. In particular, the development of biorefineries is tightly linked to the continued availability of fermentation raw materials. These constraints can be relaxed by the use of diverse raw materials, while advances that confer higher flexibility would enable biotechnological plant managers to swiftly react to volatile markets. In conventional processes, Saccharomyces cerevisiae grows on a relatively limited range of substrates, and produces only a single product,ethanol. Given the observed maturity of the S. cerevisiae fermentation technology, alternatives to baker's yeast may be needed to tip the economic balance in favour of biotechnological ethanol. These alternative fermentation technologies may allow a greater diversity of substrates to be used to produce an individually tailored mix of ethanol and other chemicals. Copyright © 2007 Society of Chemical Industry [source] Improvements in the production of bacterial synthesized biocellulose nanofibres using different culture methodsJOURNAL OF CHEMICAL TECHNOLOGY & BIOTECHNOLOGY, Issue 2 2010Amir Sani Abstract This review summarizes previous work that was done to improve the production of bacterial cellulose nanofibres. Production of biocellulose nanofibres is a subject of interest owing to the wide range of unique properties that makes this product an attractive material for many applications. Bacterial cellulose is a natural nanomaterial that has a native dimension of less than 50 nm in diameter. It is produced in the form of nanofibres, yielding a very pure cellulose product with unique physical properties that distinguish it from plant-derived cellulose. Its high surface-to-volume ratio combined with its unique properties such as poly-functionality, hydrophilicity and biocompatibility makes it a potential material for applications in the biomedical field. The purpose of this review is to summarize the methods that might help in delivering microbial cellulose to the market at a competitive cost. Different feedstocks in addition to different bioreactor systems that have been previously used are reviewed. The main challenge that exists is the low yield of the cellulosic nanofibres, which can be produced in static and agitated cultures. The static culture method has been used for many years. However, the production cost of this nanomaterial in bioreactor systems is less expensive than the static culture method. Biosynthesis in bioreactors will also be less labour intensive when scaled up. This would improve developing intermediate fermentation scale-up so that the conversion to an efficient large-scale fermentation technology will be an easy task. Copyright © 2009 Society of Chemical Industry [source] The use of colloidal gas aphrons as novel downstream processing for the recovery of astaxanthin from cells of Phaffia rhodozymaJOURNAL OF CHEMICAL TECHNOLOGY & BIOTECHNOLOGY, Issue 2 2008Maria Dermiki Abstract BACKGROUND: There is an increasing interest in obtaining natural products with bioactive properties, using fermentation technology. However, the downstream processing consisting of multiple steps can be complicated, leading to increase in the final cost of the product. Therefore there is a need for integrated, cost-effective and scalable separation processes. RESULTS: The present study investigates the use of colloidal gas aphrons (CGA), which are surfactant-stabilized microbubbles, as a novel method for downstream processing. More particularly, their application for the recovery of astaxanthin from the cells of Phaffia rhodozyma is explored. Research carried out with standard solutions of astaxanthin and CGA generated from the cationic surfactant hexadecyl trimethyl ammonium bromide (CTAB) showed that up to 90% recovery can be achieved under optimum conditions, i.e., pH 11 with NaOH 0.2 mol L,1. In the case of the cells' suspension from the fermentation broth, three different approaches were investigated: (a) the conventional integrated approach where CGA were applied directly; (b) CGA were applied to the clarified suspension of cells; and finally (c) the in situ approach, where CGA are generated within the clarified suspension of cells. Interestingly, in the case of the whole suspension (approach a) highest recoveries (78%) were achieved under the same conditions found to be optimal for the standard solutions. In addition, up to 97% recovery of total carotenoids could be achieved from the clarified suspension after pretreatment with NaOH. This pretreatment led to maximum cell disruption as well as optimum conditioning for subsequent CGA separation. CONCLUSIONS: These results demonstrate the potential of CGA for the recovery of bioactive components from complex feedstock. Copyright © 2008 Society of Chemical Industry [source] Alternative technologies for biotechnological fuel ethanol manufacturingJOURNAL OF CHEMICAL TECHNOLOGY & BIOTECHNOLOGY, Issue 8 2007Alain A Vertès Abstract The challenges of implementing biorefineries on a global scale include socioeconomic, financial, and technological constraints. In particular, the development of biorefineries is tightly linked to the continued availability of fermentation raw materials. These constraints can be relaxed by the use of diverse raw materials, while advances that confer higher flexibility would enable biotechnological plant managers to swiftly react to volatile markets. In conventional processes, Saccharomyces cerevisiae grows on a relatively limited range of substrates, and produces only a single product,ethanol. Given the observed maturity of the S. cerevisiae fermentation technology, alternatives to baker's yeast may be needed to tip the economic balance in favour of biotechnological ethanol. These alternative fermentation technologies may allow a greater diversity of substrates to be used to produce an individually tailored mix of ethanol and other chemicals. Copyright © 2007 Society of Chemical Industry [source] The Role of Biotechnology in Modern Food ProductionJOURNAL OF FOOD SCIENCE, Issue 3 2004CHERL-HO LEE ABSTRACT: Modern food production technology is given great challenges by the emerging fields of biotechnology and molecular biology. Knowledge of conventional fermentation technology is upgraded by the gene level explanations of enzyme actions and physiological functions of biomaterials derived therefrom. The use of genetically modified organisms (GMOs) and their products in food widens the availability of resources while also raising public interest about safety and labeling. As an example of the application of molecular biology in conventional fermentation technology the selection of proteases from a Bacillus species grown in Korean traditional soybean fermentation starter, Meju, and the production of peptides with blood cholesterol lowering effect, obtained from soybean protein hydrolysate, are presented. Recent developments in the Korean bioindustry are reviewed as an example of the role of biotechnology in the food industry. The present status of GMO enzymes in food production is reviewed and safety issues about GMO use in the food system are discussed. [source] Cordyceps fungi: natural products, pharmacological functions and developmental productsJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 3 2009Professor Xuanwei Zhou Abstract Objectives Parasitic Cordyceps fungi, such as Cordyceps sinensis, is a parasitic complex of fungus and caterpillar, which has been used for medicinal purposes for centuries particularly in China, Japan and other Asian countries. This article gives a general idea of the latest developments in C. sinensis research, with regard to the active chemical components, the pharmacological effects and the research and development of products in recent years. Key findings The common names for preparations include DongChongXiaCao in Chinese, winter worm summer grass in English. It has many bioactive components, such as 3,-deoxyadenosine, cordycepic acid and Cordyceps polysaccharides. It is commonly used to replenish the kidney and soothe the lung, and for the treatment of fatigue. It also can be used to treat conditions such as night sweating, hyposexuality, hyperglycaemia, hyperlipidaemia, asthenia after severe illness, respiratory disease, renal dysfunction, renal failure, arrhythmias and other heart disease and liver disease. Because of its rarity and outstanding curative effects, several mycelia strains have been isolated from natural Cordyceps and manufactured by fermentation technology, and are commonly sold as health food products. In addition, some substitutes such as C. militaris and adulterants also have been used; therefore, quality control of C. sinensis and its products is very important to ensure their safety and efficacy. Summary Recent research advances in the study of Cordyceps, including Cordyceps mushrooms, chemical components, pharmacological functions and developmental products, has been reviewed and discussed. Developing trends in the field have also been appraised. [source] | ||||||||||